Pressures on healthcare will see European companies forced into foreign ownership
This article was originally published in Clinica
Executive Summary
The inevitable drive for efficiency will leave Europe without a substantial medtech industry of its own. Cross-border mergers may be fraught with difficulties, according to Donald Meltzer of Credit Suisse First Boston, but, with the increasing emphasis on cost efficiency, further developments in this area are inevitable.